Financial Performance - The company's operating revenue for the third quarter was ¥307,520,771.89, an increase of 13.47% compared to the same period last year[4] - The total profit for the period was -¥10,619,850.65, with a year-to-date total profit of -¥117,844,163.01[4] - The net profit attributable to shareholders was -¥11,635,399.18 for the quarter, and -¥99,757,478.55 year-to-date[4] - Total operating revenue for the first three quarters of 2025 was CNY 651,727,893.79, a decrease of 21% compared to CNY 824,089,402.89 in the same period of 2024[18] - Net loss for the first three quarters of 2025 was CNY 110,790,237.75, compared to a net loss of CNY 96,212,155.89 in the same period of 2024, representing a 15.2% increase in losses[19] - The company's total equity decreased to CNY 556,808,852.85 in 2025 from CNY 662,747,807.13 in 2024, a decline of 16%[17] - The company reported a total operating profit of -48,763,660.91 RMB for the first three quarters of 2025, compared to -11,763,238.94 RMB in the previous year[31] - The company’s total comprehensive income for the first three quarters of 2025 was -49,365,355.81 RMB, reflecting a decline from -12,537,229.41 RMB in the previous year[31] Cash Flow - The cash flow from operating activities showed a net outflow of -¥69,964,026.23 year-to-date, reflecting a decrease of 20.26%[5] - The net cash flow from operating activities was -¥69,964,026.23, compared to -¥87,737,228.45 in the previous year, indicating an improvement in cash flow[24] - Cash received from sales of goods and services was CNY 815,388,511.26 in the first three quarters of 2025, down from CNY 1,185,342,300.66 in the same period of 2024, a decrease of 31.1%[22] - The cash outflow from operating activities in the first three quarters of 2025 was 318,136,018.50 RMB, significantly lower than 685,325,435.45 RMB in the same period of 2024[33] - The company’s investment activities resulted in a net cash outflow of -61,746,881.29 RMB in the first three quarters of 2025, compared to -1,350,000.00 RMB in the same period of 2024[33] Assets and Liabilities - The total assets at the end of the reporting period were ¥7,413,780,850.76, representing a 1.60% increase from the end of the previous year[5] - The company's total liabilities increased to CNY 6,856,971,997.91 in 2025 from CNY 6,634,329,373.63 in 2024, reflecting a growth of 3.4%[17] - Current liabilities totaled CNY 5,859,629,884.26, an increase of 4.1% from CNY 5,626,670,572.21 in the previous year[17] - Total assets as of September 30, 2025, amounted to ¥5,572,177,241.89, slightly up from ¥5,523,774,680.91 at the end of 2024[28] - The total liabilities increased to ¥4,489,072,854.09 from ¥4,394,210,290.92, reflecting a rise in financial obligations[28] Shareholder Information - Total number of common shareholders at the end of the reporting period is 27,842[12] - The largest shareholder, Jin Shengguang, holds 121,255,273 shares, representing 17.33% of total shares, with 119,853,110 shares pledged[12] - The company has no significant changes in the top 10 shareholders or their shareholding status compared to the previous period[13] Investment and Expenses - The company reported a significant increase in investment income by 380.76%, primarily due to debt forgiveness from non-financial institutions[9] - Research and development expenses decreased by 100%, indicating a reduction in project R&D investments during the period[9] - Research and development expenses for the first three quarters of 2025 were CNY 1,139,623.60, compared to CNY 0 in the previous year[19] - The company’s research and development expenses were not specified but are part of the overall management expenses of ¥11,904,435.46 for the first three quarters of 2025, down from ¥24,965,300.89 in 2024[30] - The company incurred credit impairment losses of 19,472,810.16 RMB in the first three quarters of 2025, compared to 44,264,570.13 RMB in the same period of 2024[31] Auditor and Accounting Standards - The company has appointed Zhongrui Cheng Accounting Firm as the external auditor for the year 2025[13] - The company has not adopted new accounting standards for the year 2025[35]

北大医药股份有限公司 2025 年第三季度报告 证券代码：000788 证券简称：北大医药 公告编号：2025-081 北大医药股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： | | 本报告期 | 本报告期比上年同 | 年初至报告期末 | 年初至报告期 末比上年同期 | | --- | --- | --- | --- | --- | | | | 期增减 | | | | | | | | 增减 | | 营业收入（元） | 273,883,890.37 | -47.95% | 1,231,193,296.53 | -19.76% | | 归属于上市公司股东的净利润（元） | 35,686,743.99 | -18.04% | 135,980,653.15 | 4.31% | | 归属于上市公司股东的扣除非经常性损益 的净利润（元） | 27,940,323.05 | -35.11% | 126,104,150.33 | -2.66% | | 经营活动产生的现金流量净额（元） | — | — | 131,738,3 ...

Financial Performance - The company's revenue for Q3 2025 was ¥238,222,453.79, representing a decrease of 12.06% compared to the same period last year[5]. - The net profit attributable to shareholders was -¥25,321,174.92, a significant decline of 2,355.45% year-on-year[5]. - The basic earnings per share for the period was -¥0.0716, reflecting a decrease of 2,337.50% compared to the previous year[5]. - Total operating revenue decreased to ¥685,656,794.86 from ¥822,664,528.62, representing a decline of approximately 16.67% year-over-year[21]. - Net profit for the period was a loss of ¥50,421,996.34, compared to a profit of ¥13,944,517.00 in the previous period, indicating a significant downturn[22]. - The company's operating profit turned negative at ¥-42,124,510.87, compared to a positive operating profit of ¥27,346,425.46 in the prior year[22]. - Basic and diluted earnings per share were both ¥-0.1487, a decrease from ¥0.0294 in the previous period[23]. Assets and Liabilities - Total assets at the end of the reporting period were ¥2,343,710,762.08, down 1.72% from the end of the previous year[5]. - Total current assets decreased from 1,439,086,278.92 CNY to 1,298,059,150.34 CNY, a reduction of approximately 9.8%[17]. - Cash and cash equivalents decreased from 383,071,864.35 CNY to 309,746,339.92 CNY, a decline of about 19.2%[17]. - Total non-current assets increased from 945,637,715.14 CNY to 1,045,651,611.74 CNY, an increase of about 10.6%[18]. - Total liabilities increased to ¥694,434,225.54 from ¥669,562,176.39, marking an increase of about 3.00%[22]. - Total equity attributable to shareholders decreased to ¥1,619,622,588.29 from ¥1,679,476,362.94, a decline of approximately 3.57%[22]. Cash Flow - The cash flow from operating activities showed a net outflow of -¥24,582,830.89, a decline of 207.34% compared to the same period last year[11]. - Cash flow from operating activities was ¥759,679,533.20, down from ¥821,350,091.16, reflecting a decline of approximately 7.51% year-over-year[25]. - Net cash flow from operating activities was -$24.58 million, a decrease from $22.90 million in the previous period[26]. - Total cash inflow from investment activities was $15.56 million, down from $309.50 million[26]. - Cash outflow from investment activities totaled $69.82 million, compared to $247.63 million previously[26]. - Net cash flow from financing activities was $23.14 million, a significant improvement from -$198.51 million[27]. - The ending cash and cash equivalents balance was $300.55 million, compared to $201.54 million at the end of the previous period[27]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 64,711[13]. - The largest shareholder, Chengdu Tianxing Instrument (Group) Co., Ltd., holds 12.45% of shares, totaling 44,002,000 shares, which are frozen and pledged[13]. Research and Development - Research and development expenses increased by 34.67% to ¥78,716,866.22, indicating a focus on innovation[10]. - The company reported a significant increase in research and development expenses to ¥78,716,866.22 from ¥58,453,739.70, an increase of about 34.67% year-over-year[22]. - The company is focusing on the development of AI-driven genetic testing technology through its collaboration with the new joint venture[15]. Investments and Joint Ventures - Investment income rose by 168.40% to ¥4,650,790.35, attributed to increased returns from joint ventures[10]. - The company recorded a fair value change gain of ¥2,203,689.24, a turnaround from a loss in the previous year[10]. - The company has established a joint venture, Henan Yuanmeng Kangtong Gene Technology Co., Ltd., to provide integrated testing services for genetic diseases in newborns and children[15]. Other Financial Metrics - Total operating costs decreased to ¥713,217,299.16 from ¥765,979,082.06, a reduction of about 6.89% year-over-year[22]. - Deferred income tax liabilities rose to ¥25,796,262.41 from ¥24,895,474.67, an increase of approximately 3.63%[22]. - Short-term borrowings increased from 113,415,839.27 CNY to 152,448,975.65 CNY, an increase of about 34.4%[18]. - The company experienced a 215.93% increase in lease liabilities, totaling ¥136,604,120.59, due to new leasing agreements[10]. - The company reported a significant increase in receivables, with a 354.19% rise in notes receivable to ¥11,750,786.08[10].

Financial Performance - The company's operating revenue for Q3 2025 reached ¥169,602,880.50, representing a 14.87% increase year-over-year[5] - Net profit attributable to shareholders was ¥4,096,797.55, up 27.32% compared to the same period last year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses surged by 413.65% to ¥3,341,912.59[5] - Total operating revenue for the current period reached ¥494,008,750.51, an increase of 11.9% compared to ¥441,455,398.80 in the previous period[17] - Net profit for the current period was ¥16,520,559.98, representing a growth of 10.1% from ¥14,864,756.03 in the previous period[19] - Operating profit increased to ¥17,739,766.59, a rise of 6.5% compared to ¥16,658,412.58 last year[18] Cash Flow - Cash flow from operating activities showed a significant improvement, with a net amount of ¥74,565,911.42, an increase of 530.27%[9] - Cash flow from operating activities generated a net amount of ¥74,565,911.42, a significant improvement from a negative cash flow of ¥17,330,129.17 in the previous period[21] - The total cash inflow from investment activities was ¥775,151,511.57, slightly down from ¥785,381,920.94 in the previous period[21] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,172,927,448.97, down 5.30% from the end of the previous year[5] - The company's total current assets decreased from 833,507,910.85 yuan to 732,003,815.09 yuan, a reduction of approximately 12.14%[13] - The total liabilities decreased from 497,676,822.38 yuan to 444,186,507.52 yuan, a reduction of approximately 10.73%[15] - The total assets decreased from 1,238,603,321.95 yuan to 1,172,927,448.97 yuan, a reduction of approximately 5.31%[15] - The company's cash and cash equivalents increased from 71,265,638.43 yuan to 99,124,645.00 yuan, an increase of approximately 39.16%[13] - The accounts receivable decreased from 336,236,990.63 yuan to 278,508,424.86 yuan, a reduction of approximately 17.14%[13] - The inventory decreased from 106,292,149.28 yuan to 93,153,659.41 yuan, a reduction of approximately 12.34%[14] Shareholder Information - The total number of common shareholders at the end of the reporting period is 10,322[10] - The largest shareholder, Xu Yangshun, holds 55.97% of the shares, totaling 41,788,377 shares[10] Earnings and Expenses - The company's basic earnings per share increased by 25.00% to ¥0.05[5] - Basic and diluted earnings per share were both ¥0.22, up from ¥0.21 in the previous period[19] - The weighted average return on equity was 0.57%, an increase of 0.12% compared to the previous year[5] - The company reported a 120.52% increase in financial expenses, totaling ¥4,095,608.84, primarily due to reduced fiscal interest subsidies[9] - Investment income decreased by 34.72% to ¥2,390,861.05, attributed to reduced financial returns and losses from subsidiary disposals[9] - Research and development expenses increased to ¥15,265,043.75, reflecting a rise from ¥14,809,258.18 in the prior period[18] - The company reported a decrease in financial expenses to ¥4,095,608.84 from ¥1,857,292.17 in the previous period, with interest expenses rising to ¥3,807,858.16 from ¥1,606,711.41[18]

Financial Performance - The company's operating revenue for the third quarter reached ¥81,052,563.30, representing a year-on-year increase of 65.01%[5] - The net profit attributable to shareholders was -¥22,542,344.70, a decrease of 50.94% compared to the same period last year[5] - The basic earnings per share were -¥0.063, down 58.03% year-on-year[5] - The company experienced a 107.52% increase in operating revenue year-to-date, attributed to the growth in new retail business sales[9] - Total operating revenue for the current period reached ¥258,555,220.53, a significant increase from ¥124,593,941.78 in the previous period, representing a growth of approximately 107.4%[19] - The net loss for the current period was ¥66,704,100.89, compared to a net loss of ¥53,831,668.06 in the previous period, reflecting a deterioration in performance[20] - The basic and diluted earnings per share for the current period were both -0.16, compared to -0.12 in the previous period[21] Assets and Liabilities - Total assets at the end of the reporting period were ¥975,201,594.76, a decrease of 4.68% from the end of the previous year[5] - Total assets decreased from ¥1,023,057,326.52 to ¥975,201,594.76, a decline of approximately 4.7%[17] - Total liabilities increased from ¥845,319,049.59 to ¥864,167,418.72, marking an increase of about 2.9%[17] - The total equity attributable to shareholders decreased from ¥254,500,523.04 to ¥197,400,472.92, a decline of approximately 22.4%[17] Cash Flow - Cash flow from operating activities showed a net outflow of -¥172,352,555.05, a decrease of 250.37% compared to the same period last year[5] - Cash inflow from operating activities totaled $485.73 million, up from $347.93 million in the previous period, representing a 39.6% increase[23] - Cash outflow from operating activities increased to $658.08 million from $397.12 million, resulting in a net cash flow from operating activities of -$172.35 million, compared to -$49.19 million previously[24] - The company reported a net decrease in cash and cash equivalents of $14.63 million, contrasting with an increase of $11.69 million in the previous period[24] - The ending balance of cash and cash equivalents was $86.19 million, down from $117.08 million year-over-year[24] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 19,099[10] - The top shareholder, Wuxin Investment Holdings, holds 28.06% of the shares, totaling 100,000,000 shares[10] - The company has a significant shareholder, Wuxin Investment Holdings, which holds 100,000,000 shares of common stock, representing a substantial portion of the company's equity[11] - The company has not reported any changes in the participation of major shareholders in margin trading activities[11] Operating Costs and Expenses - The company reported a significant increase in operating costs, which rose by 123.28% year-on-year, primarily due to increased sales costs in the new retail business[9] - Total operating costs amounted to ¥314,262,169.70, up from ¥156,522,723.70, indicating an increase of about 100.5%[19] - The company reported a significant increase in sales expenses, which rose to ¥39,669,501.05 from ¥12,411,073.58, an increase of approximately 219.5%[19] - The company’s financial expenses increased by 36.27%, mainly due to an increase in borrowings from related parties[9] Litigation and Governance - The company is involved in ongoing litigation related to a dispute with its former controlling shareholder, which may impact future operations and financial results[12] - The company plans to eliminate the supervisory board, transferring its responsibilities to the audit committee of the board of directors, effective from September 15, 2025[13] - The company has received a civil ruling from the Supreme People's Court, indicating that the original judgment was flawed and will be retried[13] - The company is actively monitoring the developments in the ongoing litigation and will provide updates as necessary[12] Other Financial Metrics - Cash inflow from financing activities was $190.09 million, compared to $100 million in the prior period, marking a 90.1% increase[24] - Net cash flow from financing activities improved to $158.34 million from $60.18 million, indicating a significant increase in financing efficiency[24] - The company paid $25.41 million in employee compensation, slightly up from $24.19 million, reflecting a 5.1% increase in labor costs[24] - Tax payments surged to $162.34 million from $9.73 million, indicating a substantial increase in tax liabilities[24] - The company invested $610.59 thousand in fixed assets, up from $346.79 thousand, showing a commitment to capital expenditure[24] - The third quarter financial report was not audited, which may impact the reliability of the reported figures[26]

Financial Performance - The company's operating revenue for Q3 2025 reached ¥15,917,165,202.83, representing a 77.91% increase compared to the same period last year[8] - Net profit attributable to shareholders was ¥352,485,860.96, a significant increase of 525.14% year-on-year[8] - The net profit after deducting non-recurring gains and losses was ¥227,194,986.46, reflecting a 204.05% increase compared to the previous year[8] - Basic and diluted earnings per share were both ¥0.0716, marking a 500% increase from the same period last year[8] - The total profit for the period was ¥121,998,562.04, down from ¥178,577,326.40, indicating a decrease of about 31.66%[34] - The net profit attributable to shareholders of the parent company was ¥372,141,671.35, a decline of approximately 12.2% from ¥423,896,921.27[35] - The company reported a total comprehensive income of ¥395,704,447.66, compared to ¥488,745,563.76 in the previous period, a decrease of approximately 19.0%[35] - The basic and diluted earnings per share decreased to ¥0.0756 from ¥0.0861, representing a decline of about 12.9%[35] Cash Flow - The net cash flow from operating activities increased by 315.09% to ¥3,512,754,083.47, primarily due to improved cash collection[9] - The company reported a net increase in cash and cash equivalents of ¥1.22 billion, a 133.97% increase from a decrease of ¥3.58 billion in the previous year[19] - Net cash flow from operating activities reached ¥3.51 billion, a 315.09% increase from a negative cash flow of ¥1.63 billion in the same period last year[19] - The net cash flow from investing activities was -¥2.05 billion, a decrease of 78.39% compared to -¥1.15 billion in the previous year[19] - The investment activities resulted in a net cash outflow of ¥2,050,060,491.33, worsening from a net outflow of ¥1,149,222,468.43 in the previous period[37] - Net cash flow from financing activities improved to -¥248.86 million, a 70.03% reduction from -¥830.29 million in the prior year[19] Assets and Liabilities - Total assets at the end of the reporting period were ¥76,195,233,089.08, up 4.74% from the end of the previous year[10] - Total liabilities increased to ¥49,461,724,738.47 from ¥46,154,569,883.88, marking a growth of 5.0%[31] - Total equity attributable to shareholders rose to ¥26,412,715,885.44, up from ¥26,317,926,062.66, reflecting a growth of 0.4%[31] - Non-current assets total ¥23,638,423,192.17, an increase of 5.5% from ¥22,414,256,280.38[30] - Deferred income tax assets increased to ¥3,412,919,743.29 from ¥3,061,404,632.44, a growth of 11.5%[30] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 81,966, with no preferred shareholders restoring voting rights[21] - The largest shareholder, China First Automobile Group Co., Ltd., holds 62.19% of the shares, totaling 3,060,649,901 shares[21] Operational Highlights - The company plans to continue its market expansion and product development strategies, focusing on enhancing operational efficiency and profitability[24] - The company experienced a 48.65% increase in accounts receivable, totaling ¥10,505,245,413.35[16] - The company recorded a 33.90% increase in taxes and surcharges due to higher production and sales volumes[17] - Research and development expenses were ¥1,377,367,102.13, down from ¥1,732,755,866.75, reflecting a reduction of about 20.5%[34] - The company has approved a stock repurchase plan for 1,090,201 shares due to unmet vesting conditions for certain incentive stock options[26] - The company is engaged in ongoing discussions regarding expected related party transactions for the fiscal year 2025[26] Inventory and Receivables - Accounts receivable rose to ¥10,505,245,413.35, up 48.5% from ¥7,067,296,142.54[29] - Inventory increased to ¥12,981,489,899.14, a rise of 28.3% from ¥10,117,213,109.97[29]

Financial Performance - The company's operating revenue for Q3 2025 was ¥410,213,554.70, representing a year-on-year increase of 9.17%[5] - The net profit attributable to shareholders for Q3 2025 was -¥7,899,534.53, an increase in loss of 8.20% compared to the same period last year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥7,981,604.99, a deterioration of 24.04% year-on-year[5] - The net profit for the current period was a loss of ¥29,363,620.33, compared to a loss of ¥23,125,175.29 in the previous period, indicating a deterioration in performance[18] - The total comprehensive income attributable to the parent company was a loss of ¥29,338,430.15, compared to a loss of ¥23,099,268.14 in the previous period, indicating a decline in overall financial performance[18] Assets and Liabilities - The total assets at the end of Q3 2025 were ¥889,187,570.79, a decrease of 3.44% from the end of the previous year[5] - The total amount of current assets is RMB 708,741,243.81, a decrease from RMB 727,735,322.95 at the beginning of the period[14] - The total amount of non-current assets is RMB 180,446,326.98, down from RMB 193,124,743.73[14] - Total liabilities amount to RMB 818,074,259.77, slightly down from RMB 820,383,135.34[15] - The total equity attributable to the parent company decreased to RMB 70,977,052.62 from RMB 100,315,482.77, a decline of approximately 29%[15] Cash Flow - The cash flow from operating activities for the year-to-date was -¥23,011,786.75, a significant decline of 69.98%[5] - The net cash flow from operating activities was negative at ¥23,011,786.75, an improvement from a negative cash flow of ¥76,651,616.48 in the previous period[20] - The total cash inflow from operating activities was ¥1,232,983,326.76, compared to ¥1,126,628,125.08 in the previous period, marking an increase of approximately 9.4%[20] - Cash and cash equivalents decreased to RMB 17,921,664.64 from RMB 55,184,731.89[13] - Cash and cash equivalents at the end of the period decreased to ¥12,073,877.23 from ¥44,983,517.21, a decline of approximately 73%[21] Shareholder Information - The total number of common shareholders at the end of the reporting period is 38,025[11] - The top shareholder, Xiaochang Yingxi Valley Investment Center, holds 22.61% of shares, amounting to 211,721,085 shares[11] Borrowings and Expenses - The company experienced a 100% increase in long-term borrowings, adding ¥10,000,000 during the period[9] - The company incurred a financial expense of ¥2,888,700.29, which is an increase from ¥2,266,648.02, reflecting a rise of about 27.5%[17] Operating Costs and R&D - Total operating revenue for the current period reached ¥1,185,976,115.22, an increase of 10% compared to ¥1,078,076,032.31 in the previous period[17] - Total operating costs increased to ¥1,214,629,952.83, up from ¥1,100,735,924.64, reflecting a rise of approximately 10.3%[17] - Research and development expenses increased to ¥39,559,539.99, up from ¥36,701,432.35, reflecting a growth of about 7.7%[17] Asset Disposal and Taxes - The company recorded a 1131.19% increase in asset disposal gains compared to the same period last year, amounting to an increase of ¥154,500[9] - The company reported a 218.44% increase in taxes and surcharges compared to the same period last year, amounting to an increase of ¥1,344,400[9] Share Performance - The weighted average return on net assets was -10.54%, a decrease of 3.19 percentage points compared to the previous year[5] - The company reported a basic and diluted earnings per share of -0.0313, compared to -0.0247 in the previous period, indicating a worsening in earnings per share[18]

奥维通信股份有限公司 2025 年第三季度报告 证券代码：002231 证券简称：*ST 奥维 公告编号：2025-077 奥维通信股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息 的真实、准确、完整。 3.第三季度财务会计报告是否经过审计 □是 否 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 （二） 非经常性损益项目和金额 适用 □不适用 | | | 单位：元 | | | --- | --- | --- | --- | | 项目 | 本报告期金额 | 年初至报告期期末金额 | 说明 | | 非流动性资产处置损益 （包括已计提资产减值准 | 168,527.22 | 66,549.23 | | | 备的冲销部分） ...

Financial Performance - The company's operating revenue for Q3 2025 was ¥183,796,710.56, a decrease of 27.31% compared to the same period last year[5] - The net profit attributable to shareholders was -¥6,783,012.85, representing an increase in loss of 83.53% year-on-year[5] - The net profit after deducting non-recurring gains and losses was -¥15,711,656.83, a decrease in loss of 75.56% compared to the previous year[5] - The basic earnings per share were -¥0.02, an increase in loss of 80.00% year-on-year[5] - The company reported a significant decrease in total operating income of 52.02%, primarily due to reduced revenue from home decoration services[10] - Total operating revenue for the current period was ¥544.29 million, a decrease of 52.0% compared to ¥1,134.49 million in the previous period[21] - Net profit for the current period was a loss of ¥53.81 million, an improvement from a loss of ¥583.45 million in the previous period[22] - The total comprehensive income attributable to the parent company was -58,374,545.93 CNY, compared to -581,354,719.81 CNY in the previous period, indicating a significant improvement[23] - Basic and diluted earnings per share were both -0.14 CNY, an improvement from -1.39 CNY in the previous period[23] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,420,728,217.35, down 15.60% from the end of the previous year[5] - The company's total assets decreased to ¥1,420.73 million from ¥1,683.32 million, a decline of 15.6%[19] - Current liabilities totaled ¥2,326.62 million, down 6.2% from ¥2,481.43 million in the previous period[19] - Non-current liabilities decreased to ¥122.65 million from ¥176.44 million, a reduction of 30.4%[19] - The company's total equity showed a decline, with total equity at -¥1,028.54 million compared to -¥974.55 million in the previous period[19] Cash Flow - The net cash flow from operating activities was -7,442.66 million, an improvement of 22.83% compared to -9,644.08 million in the previous period[11] - The net cash flow from investing activities increased significantly to 1,643.25 million, a 108.90% improvement from -18,473.20 million in the prior period[11] - The net cash flow from financing activities was 4,636.49 million, representing a 133.01% increase compared to -14,046.14 million in the previous period[11] - The company's cash flow from financing activities showed a net increase of 46,364,857.69 CNY, contrasting with a net outflow of -140,461,438.10 CNY in the previous period[25] - The net cash flow from operating activities was -74,426,571.32 CNY, an improvement from -96,440,764.47 CNY year-over-year[24] - The total cash inflow from operating activities was 562,371,548.83 CNY, down from 1,122,203,879.72 CNY, a decrease of approximately 50.1%[24] Shareholder Information - The total number of common shareholders at the end of the reporting period was 12,139[13] - The largest shareholder, Tianjin Dongyi Tianzheng Investment Co., Ltd., holds 16.15% of shares, totaling 67,738,128 shares[13] - The second-largest shareholder, Tianjin Chenshang Consulting Co., Ltd., owns 15.87% of shares, amounting to 66,578,594 shares[13] Restructuring and Legal Matters - The company has selected 11 investors as restructuring investors as of September 26, 2025[15] - The restructuring plan and related voting notifications were sent to creditors on October 9, 2025, with subsequent approval of the plan on October 15, 2025[15] Expenses - Research and development expenses decreased by 35.94% to ¥3,402.66, attributed to a reduction in personnel and salaries[10] - Research and development expenses for the current period were ¥34.03 million, a decrease of 36.0% from ¥53.12 million in the previous period[22] - The company reported a significant reduction in sales expenses, which were ¥111.71 million, down 72.9% from ¥412.64 million in the previous period[22] - The income tax expense was -851.26 million, reflecting a 336.51% increase due to the provision for deferred tax assets[11] Asset Disposal - The company reported a significant decrease in asset disposal income, down 93.05% to 203.44 million, primarily due to reduced income from the disposal of usage rights assets[11] - The company recorded a non-recurring gain of ¥8,928,643.98, primarily from pending litigation and debt claims[7]

重要内容提示： 深圳市郑中设计股份有限公司 2025 年第三季度报告 证券代码：002811 证券简称：郑中设计 公告编号：2025-069 深圳市郑中设计股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 深圳市郑中设计股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入（元） | 357,041,643.64 | 15.45% | 9 ...